News Releases

DURHAM, N.C., July 20, 2018 /PRNewswire/ -- uMETHOD Health, a healthcare technology company that provides precision medicine solutions to physicians treating Alzheimer's and other chronic conditions, announced today that the company will present its work across five diverse areas related to cognitive decline and mild Alzheimer's disease at the 2018 Alzheimer's Association International Conference (AAIC) held July 22-26^th in Chicago.

The following will be presented at this year's meeting. Authors include Dorothy Keine, MS, and John Q. Walker II, PhD, of uMETHOD, and Marwan N. Sabbagh, MD, who was named Director of the Cleveland Clinic Lou Ruvo Center for Brain Health, effective May 1, 2018:

• Development, Application, and Results from a Precision-Medicine Platform that Personalizes Multi-modal Combination Therapy Care Plans for Mild Alzheimer's Disease and Those At-Risk.
• Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms.
• Observations on the Influence of Drug Interactions on Multi-modal Combination Therapy Care Plans to Address Contributors to Cognitive Decline.
• Observations on the Frequency of Depression and Medications in an APOE ε4 Vs non-APOE ε4 Population.
• Observations on Coaching in Managing Lifestyle and Behavioral Changes in Multi-modal Combination Therapy Care Plans for Cognitive Impairment.

About the AAIC

The Alzheimer's Association International Conference® (AAIC®) is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world's leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that will lead to methods of prevention and treatment, and improvements in diagnosis for Alzheimer's disease.

About uMETHOD

uMETHOD's AI platform generates personalized treatment plans for chronic diseases. uMETHOD's RestoreU METHOD treatment plans for Alzheimer's and dementia patients are based on data from the patient's genome, bio-specimens, medical history, demographics, medications, lifestyle and other factors. The company works with physicians across the country and also matches patients with personal coaches to support and encourage program adherence. For more information visit www.umethod.com.

PRESS CONTACT: 
Helen Bertelli, Benecomms
(202) 465-1468, helen@benecomms.io

SOURCE uMETHOD Health